While we could provide evidence that XAF1 methylation is strictly (100%) linked to 2-HG-producing mutations in IDH1 (shown for R132H, R132G) in grade III gliomas, we were not able to identify a less frequent IDH2-mutant tumor within the data set. This evidence concerns the gene IDH1 and central nervous system cancer.